Publications

(*First authors; #Corresponding authors)

Featured Publications: 

  1. Xu Y*, Anirudhan V*, Gaisina I, Du H, Alqarni S, Moore T, Caffrey M, Manicassamy B, Zhou T, Rong L#, Xu K#. Mechanistic insights into the small molecule inhibition of influenza A virus entry. (2025) PNAS. Aug 13.

  2. Xu J*, Xu K*, Jung S, Conte A, Lieberman J, Muecksch F, Lorenzi JCC, Park S, Schmidt F, Wang Z, Huang Y, Luo Y, Nair M, Wang P, Schulz JE, Tessarollo L, Bylund T, Chuang GY, Olia AS, Stephens T, Teng IT, Tsybovsky Y, Zhou T, Munster V, Ho DD, Hatziioannou T, Bieniasz PD, Nussenzweig MC, Kwong PD, Casellas R. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. (2021) Nature. Jun 7.

  3. Xu K*#, Wang Y, Shen CH, Chen Y, Zhang B, Liu K, Tsybovsky Y, Wang S, Farney SK, Gorman J, Stephens T, Verardi R, Yang Y, Zhou T, Chuang GY, Lanzavecchia A, Piccoli L, Kwong PD#. Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINs. (2021) Nat Commun. Jul 9.

  4. Xu K*, Acharya P*, Kong R*, Cheng C*, et al, Mascola JR, Kwong PD. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. (2018) Nat Med. Jun 24.

 

Complete List of Published Work in: My Bibliography, Google Scholar

 

Additional Publications:

  1. Ramesh AK, Sivaccumar JP, Ye X, Yang L, Guo H, Chin CN, Ha S, Shiver JW, Strohl WR, Xu Y, Du H, Zhou T, Zhang N, Xu K#, Liu X#, Fu TM#, An Z#. An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses.  (2025) Nat Commun. Apr 29;16(1):4025.
  2. Qu P, Evans JP, Faraone JN, Zheng YM, Carlin C, Anghelina M, Stevens P, Fernandez S, Jones D, Lozanski G, Panchal A, Saif LJ, Oltz EM, Xu K, Gumina RJ, Liu SL. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. (2023) Cell Host Microbe. Jan 11;31(1):9-17.e3.
  3. Wang Z*, Dang HV*, Amaya M*, Xu Y*, Yin R, Yan L, Hickey AC, Annand EJ, Horsburgh BA, Reid PA, Smith I, Eden JS, Xu K#, Broder CC#, Veesler D#. Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant. (2022) PNAS. May 31;119(22)
  4. Laing ED, Navaratnarajah CK, Cheliout Da Silva S, et al, Broder CC# and Xu K#. Structural and functional analyses reveal promiscuous and species-specific use of ephrin receptors by Cedar virus. (2019) PNAS. Oct 8;116(41):20707-20715.
  5. Qu P, Xu K, Faraone JN, Goodarzi N, Zheng YM, Carlin C, Bednash JS, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Gumina RJ, Liu SL. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. (2024) Cell. Feb 1;187(3):585-595.e6
  6. Chen Y*, Xu K*, Piccoli L, Foglierini M, Tan J, Jin W, Gorman J, Tsybovsky Y, Zhang B, Traore B, Silacci-Fregni C, Daubenberger C, Crompton P.D., Geiger R, Sallusto F, Kwong P.D. & Lanzavecchia A. Structural basis of malaria RIFIN binding by LILRB1-containing antibodies (2021) Nature Apr;592(7855):639-643. PMID: 33790470
  7. Kong R*, Duan H*, Sheng Z*, Xu K*, Acharya P*, Chen X*, Cheng C*, Dingens AS*, Gorman J*, Sastry M*, Shen CH*, Zhang B*, Zhou T*, et al, Kwong PD, Mascola JR. Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization. (2019) Cell. Jul 25; 178(3): 567-584.
  8. Kong R*, Xu K*, Zhou T*, et al, Kwong PD, Mascola JR. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody. (2016) Science. May 13;352(6287):828-33.
  9. Xu K*, Wu Z, Renier N, Antipenko A, Tzvetkova-Robev D, Xu Y, Minchenko M, Nardi-Dei V, Rajashankar KR, Himanen J, Tessier-Lavigne M, Nikolov DB. Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism. (2014) Science. 344(6189):1275-9.